XML 47 R36.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)
 6 Months Ended
Apr. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill balances and movements for each reportable segment during the period
The following table presents goodwill balances and the movements for each of our reportable segments during the six months ended April 30, 2024:
 
 Life Sciences and Applied MarketsDiagnostics and GenomicsAgilent CrossLabTotal
 (in millions)
Goodwill as of October 31, 2023$1,579 $2,124 $257 $3,960 
Foreign currency translation impact2 — 1 3 
Goodwill as of April 30, 2024$1,581 $2,124 $258 $3,963 
Components of other intangible assets during the period
The component parts of other intangible assets as of October 31, 2023 and April 30, 2024 are shown in the table below:
 
 Other Intangible Assets
 Gross
Carrying
Amount		Accumulated
Amortization		Net Book
Value
 (in millions)
As of October 31, 2023   
Purchased technology$1,467 $1,093 $374 
Trademark/Tradename196 163 33 
Customer relationships149 112 37 
Third-party technology and licenses34 13 21 
Total amortizable intangible assets1,846 1,381 465 
In-Process R&D10 — 10 
Total$1,856 $1,381 $475 
As of April 30, 2024   
Purchased technology$1,473 $1,131 $342 
Trademark/Tradename196 170 26 
Customer relationships149 118 31 
Third-party technology and licenses34 16 18 
Total amortizable intangible assets1,852 1,435 417 
In-Process R&D— — — 
Total$1,852 $1,435 $417 
Schedule of estimated future amortization expense of finite-lived intangible assets
Future amortization expense related to existing finite-lived purchased intangible assets for the remainder of fiscal year 2024 and for each of the next five fiscal years and thereafter is estimated below:
Estimated future amortization expense:
(in millions)
Remainder of 2024$48 
2025$84 
2026$54 
2027$53 
2028$46 
2029$42 
Thereafter$90